secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-05-22T21:22:44+00:00
Accession:  0001193125-26-237195
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health issues 54k shares to Streeterville in exchange for Series Q preferred; adjourns annual meeting to June 2
--------------------------------------------------------------------------------

- Issued 54,222 common shares to Streeterville in exchange for 7.96 shares of Series Q Preferred Stock.
- Common shares to be issued without restrictive legend; Streeterville can resell under Rule 144 using tacked holding period from Aug 2022.
- Annual Meeting adjourned to June 2, 2026; supplement to proxy to be filed after discussions with Nasdaq staff.
- Company plans to provide additional information to stockholders regarding certain proposals in the proxy statement.
- Record date remains April 15, 2026 for the reconvened meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526237195/0001193125-26-237195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526237195/d138181d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-237195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer